Sexually Transmitted Infections Clinical Trial
Official title:
Prospective Cohort Trial To Assess Acceptability and Efficacy of an Adapted STI/HIV Intervention Behavioral Intervention Program in a Population of US Army Personnel and Their Medical Beneficiaries - Execution Phase
The hypothesis is that a behavioral intervention tool adapted for the US military population will be acceptable and associated with a decrease in incident sexually transmitted infection (STI)/HIV rates and high-risk sexual behaviors, and increased self-reported condom use compared to the standard of care at the Joint Base Lewis-McChord (JBLM) Preventive Medicine clinic and the Fort Bragg Department of Public Health (part of Womack Army Medical Center).
This is the Execution Phase which will be conducted as a multi-site randomized controlled trial. A previous Formative Phase study was conducted under a separate protocol which has been completed with preliminary data indicating positive outcomes. Participants in both arms will meet the same inclusion/exclusion criteria and will be randomized into the intervention and control arms at a ratio of 1:1. The intervention arm will receive the KISS (Knocking out Infections through Safer sex and Screening) intervention program in addition to standard STI prevention counselling routinely provided by military medical treatment facilities. The control arm will receive only standard STI prevention counselling. Both arms will receive follow-up educational messages via short message service (SMS)/text messaging monthly for 10 months, and have follow-up study visits at 6 months and 12 months. The KISS intervention is a 2-hour, small group (6-12 individuals) class-based interactive, educational session based on Social Cognitive Theory and the Theory of Gender and Power. The intervention is an adaptation of the HORIZONS intervention, which has shown efficacy are reducing sexual risk behavior and incident STIs among adolescents in the USA. HORIZONS has been reviewed by the U.S. Centers for Disease Control (CDC) Prevention Synthesis Research team and designated a CDC top-tier (Tier I) evidence-based intervention (EBI). To enroll in the study, participants must be categorized as "high risk" as determined by a positive test for an STI within the previous 180 days or has had STI screening during this time frame (specifically gonorrhea (GC), chlamydia (CT), M. genitalium, syphilis and/or HIV). Study subjects will be recruited from Madigan Army Medical Center (Madigan) Preventive Medicine Clinic and the Womack Army Medical Center (Womack) Preventive Medicine Clinic in Ft. Bragg, North Carolina (NC). In addition, promotional flyers for recruitment will be placed in public areas on both bases, and will be promoted through approved social media channels. Subjects may also refer up to 5 friends or colleagues for screening. Participants enrolled in the intervention arm will complete a total of four visits and those in the control arm will complete a total of three visits. Over the course of the study, participants in both groups will be asked to provide biological specimens and complete knowledge/behavioral surveys three times (at baseline, 6 and at 12 months). Those in the intervention group will also attend the KISS EBI (Evidence Based Intervention) program. Both arms will receive monthly (months 2-11) follow up text messages, but the content will defer between the two arms. Those in the intervention arm, will receive SMS/text messages targeting prevention maintenance interventions (PMI) messages reiterating information received during the EBI session. Those in the control arm, will receive SMS/text messages that will contain general health information. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01144871 -
Parental Knowledge and Attitudes of Confidential Sexually Transmitted Infections (STI) Services for Teens
|
N/A | |
Completed |
NCT04661566 -
Optimizing a Multi-Modal Intervention to Reduce Health-Risking Sexual Behaviors: Component Selection
|
N/A | |
Completed |
NCT01842100 -
To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy
|
N/A | |
Completed |
NCT04867798 -
Transgender Men and HIV in Uganda: PrEP Uptake and Persistence
|
||
Active, not recruiting |
NCT04328025 -
Peer-Delivered HIV Self-Testing, STI Self-Sampling and PrEP for Transgender Women in Uganda
|
N/A | |
Completed |
NCT02509572 -
Improvement of STI Detection in Adolescent Emergency Department Patients
|
N/A | |
Active, not recruiting |
NCT04758390 -
A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women
|
N/A | |
Completed |
NCT03528135 -
Project PRIDE (Promoting Resilience In Discriminatory Environments)
|
N/A | |
Completed |
NCT02461940 -
STI/HIV Prevention Intervention for Adolescents in Singapore
|
N/A | |
Completed |
NCT01784809 -
The Multimedia HIV/STI Prevention for Drug-Involved Female Offenders
|
Phase 2 | |
Completed |
NCT01136850 -
Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea
|
Phase 3 | |
Completed |
NCT00469547 -
62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides
|
Phase 1 | |
Completed |
NCT01285349 -
HIV/STI Prevention for Drug-Involved Couples
|
N/A | |
Completed |
NCT02391233 -
Multimedia WORTH With Black Drug-Involved Women on Probation
|
N/A | |
Completed |
NCT02183909 -
Connecting Resources for Urban Sexual Health
|
N/A | |
Completed |
NCT02882607 -
Peer Groups for Healthy Pregnancy & HIV Prevention for Young Malawian Women
|
N/A | |
Completed |
NCT00362375 -
Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04710784 -
A Pragmatic Trial to Expand Youth-friendly HIV Self-testing
|
N/A | |
Recruiting |
NCT06223165 -
Optimizing the Floreciendo Sexual and Reproductive Health Workshop for Latina Teens and Female Caregivers: A Pilot
|
N/A | |
Completed |
NCT05319613 -
Reducing Disparities in Rural HIV Prevention
|
N/A |